- Filed
- May 7, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2025 · May 5, 2025 | 155.44M sh |
| Long Term Debt | Q3 2025 · Mar 31, 2025 | $3.73B |
| Long Term Debt | Q3 2025 · Jun 30, 2024 | $4.03B |
| Short Term Debt | Q3 2025 · Mar 31, 2025 | $4.67M |
| Short Term Debt | Q3 2025 · Jun 30, 2024 | $73.77M |
| Stockholders Equity | Q3 2025 · Mar 31, 2025 | $5.35B |
| Stockholders Equity | Q3 2025 · Jun 30, 2024 | $5.21B |
| Current Liabilities | Q3 2025 · Mar 31, 2025 | $1.5B |
| Current Liabilities | Q3 2025 · Jun 30, 2024 | $1.34B |
| Total Liabilities | Q3 2025 · Mar 31, 2025 | $6.28B |
| Total Liabilities | Q3 2025 · Jun 30, 2024 | $6.54B |
| Current Assets | Q3 2025 · Mar 31, 2025 | $3.7B |
| Current Assets | Q3 2025 · Jun 30, 2024 | $3.66B |
| Total Assets | Q3 2025 · Mar 31, 2025 | $14.44B |
| Total Assets | Q3 2025 · Jun 30, 2024 | $14.49B |
| Cash And Equivalents | Q3 2025 · Jun 30, 2024 | $926.03M |
| Cash And Equivalents | Q3 2025 · Mar 31, 2024 | $898.58M |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 152.14M sh |
| Shares Diluted | Q3 2025 · Mar 31, 2024 | 151.34M sh |
| Capex | Q3 2025 · Mar 31, 2024 | $246.91M |
| Operating Cash Flow | Q3 2025 · Mar 31, 2024 | $383.4M |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$0.29 |
| Eps Diluted | Q3 2025 · Mar 31, 2024 | −$1.32 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$0.29 |
| Eps Basic | Q3 2025 · Mar 31, 2024 | −$1.32 |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $205.17M |
| Sga Expense | Q3 2025 · Mar 31, 2024 | $626.03M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $127.49M |
| Rd Expense | Q3 2025 · Mar 31, 2024 | $352.14M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$13.19M |
| Net Income | Q3 2025 · Mar 31, 2024 | −$107.71M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $842.32M |
| Cost Of Revenue | Q3 2025 · Mar 31, 2024 | $2.37B |
| Revenue | Q3 2025 · Mar 31, 2024 | $1.21B |
| Revenue | Q3 2025 · Mar 31, 2024 | $3.39B |